← Back to Browse
ProductLaboratory Equipment

Microfluidics Technology Platform

Zhubei City, Hsinchu County, Taiwan

Proprietary microfluidics technology platform designed for point-of-care testing and molecular diagnostics applications. Enables precise fluid handling and sample processing in miniaturized formats for rapid diagnostic analysis.

Manufactured by

MedFluid Co., Ltd.

Zhubei City, Hsinchu County, Taiwan

https://medfluid.com.tw/ NAST, the world s first in-clinic antibiotic susceptibility test analyzer. Founded in 2019 by experts in microfluidics, p owered by patented microfluidics, NAST delivers accurate results within 6 hours. Validated over 4 years in veterinary markets, it enables rapid, evidence-based treatment decisions for animal care. The team develops microfluidic platforms for rapid detection tools of disease diagnosis and precision treatments to improve the health and well-being of patients.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 55 closest product alternatives

55 products

52 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products